ANAVEX 2-73 advances Phase I clinical trial for Alzheimer’s disease
Monday, May 23rd, 2011Anavex Life Sciences Corp.
Go here to read the rest:
ANAVEX 2-73 advances Phase I clinical trial for Alzheimer’s disease
Anavex Life Sciences Corp.
Go here to read the rest:
ANAVEX 2-73 advances Phase I clinical trial for Alzheimer’s disease